WASHINGTON (dpa-AFX) - Boston Scientific Corporation (BSX) Monday said it has agreed to acquire medical technology company Cortex, Inc.
Financial terms of the deal have not been disclosed.
Cortex's OptiMap, a diagnostic mapping solution, helps physicians to identify triggers outside of the pulmonary veins that are foundational to atrial fibrillation (AF), a heart rhythm disorder.
'We believe the addition of the Cortex technology complements our electrophysiology portfolio with a differentiated cardiac mapping offering to assist with complex AF cases,' said Nick Spadea-Anello, global president, Electrophysiology, Boston Scientific.
Boston Scientific expects to complete the transaction in the first half of 2025.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2024 AFX News
